NTpharma LLCNTpharma LLC

Production of vaccines and biopharmaceuticals based on pseudoadenoviral nanoparticles and special nanostructuresProduction of vaccines and biopharmaceuticals based on pseudoadenoviral nanoparticles and special nanostructures

Project details

The project provides for building a facility for production of vaccines and pharmaceuticals in the municipal area of Pereslavl’-Zalessky, 150 kilometers (85 miles) northeast of Moscow.
The project aims at production of new generation vaccines, including a polyvalent human flu vaccine, and for treatment of amyotrophic lateral sclerosis (ALS/Lou Gehrig’s disease).
NTpharma’s technology allows to reduce by half the time required for culturing and production of the vaccine. This advantage is vital when dealing with vaccines for pandemic flu strains spreading rapidly all over the world.
All vaccines and pharmaceuticals are protected intellectual property of NTpharma LLC.

Project’s social effect:

 

  • 150 new jobs;
  • absence of harmful emissions to the environment;
  • reduced dependency on imported vaccines;
  • reasonable price compared to imported vaccines.

 

 

Competitive advantages:

 

  • vaccine production speed increased up to 2 times;
  • the first vaccine for  influenza with intranasal form of administration;
  • the absence of virus replication in cells;
  • manufacturing strains on cell culture eliminating side allergic reactions;
  • a genetic vaccine with artificially synthesized antigenic structure;
  • forming a stable viral resistance in 2 to 3 weeks;
  • an original no-analogue pharmaceutical  for  treatment of amyotrophic lateral sclerosis.

 

 

Project participants:


  • RUSNANO JSC;
  • Federal Research Centre for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya of the Ministry of Health of the Russian Federation – coordination the scientific part of the work;
  • State Scientific Center “Institute of Immunology” of the Russian Federal Medical and Biological Agency;
  • Research Institute of Influenza of the Ministry of Health and Social Development of the Russian Federation;
  • Research Institute of Pulmonology of the Ministry of the Russian Federal Medical and Biological Agency;

Scientific support is also provided by Molecular Genetics Institute of the Russian Academy of Science, Scientific Center for Neurology of RAMS, Petrovsky Russian State Surgery Center of RAMS, Russian Research Institute of Animal Protection and other scientific institutions.

 

Map

Close window

Map

Close window